semaglutide and blood clots Does cause clots? What the research actually shows Dear Doctor: Is there evidence

In SURMOUNT-5, GI adverse events leading to treatment discontinuation were 5.6% for semaglutide vs 2.7% for tirzepatide, suggesting a possible tolerability advantage for tirzepatide in that trial context

Consume high-fiber foods, fermented products, and protein-rich meals

Tirzepatide stood out by reducing anxiety risk in diabetic patients by 60%

This refers to the exact number of amino acids in the peptide chain

Some patients experience irritation at the injection site, which can be avoided with a sublingual method

The gut-brain axis is a bidirectional communication system between your gastrointestinal tract and your central nervous system